Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Bezlotoxumab (BEZLO) In Addition To Standard Of Care (SOC) Vancomycin For The Treatment of Multi-Recurrent Clostridium Difficile Infection

University of Kansas Medical Center · 2019
ClinicalTrials.gov · Datasets · License: Public Domain · 2019
Open Source ↗
recurrence
clostridium difficile infection recurrence, c.diff, clostridium difficile, recurrence, bezlotoxumab, cdi, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 891531
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.